Showing posts with label type 2 diabetes. Show all posts
Showing posts with label type 2 diabetes. Show all posts
Monday, March 4, 2024

FDA Approves Brenzavvy (bexagliflozin) for the Treatment of Adults with Type 2 Diabetes

›
TheracosBio  announced  the U.S. Food and Drug Administration (FDA)   approval of  Brenzavvy (bexagliflozin), an oral sodium-glucose cotrans...
Friday, March 20, 2020

FDA Approves Rybelsus (semaglutide), the First Oral GLP-1 Analog Treatment for Adults with Type 2 Diabetes

›
In continuation of my updates on Semaglutide Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has appro...
Thursday, October 10, 2019

FDA Approves Victoza (liraglutide) for the Treatment of Pediatric Patients 10 Years or Older with Type 2 Diabetes

›
In continuation of my update on Victoza (liraglutide) The U.S. Food and Drug Administration   approved Victoza (liraglutide) injection...
Tuesday, July 2, 2019

FDA Approves Qternmet XR (dapagliflozin, saxagliptin and metformin hydrochloride) for Type 2 Diabetes

›
In continuation of my update on  dapagliflozin , and metformin hydrochloride   Dapagliflozin               Saxagliptin    ...
Saturday, September 22, 2018

Eating plant-based diet can reduce risk for heart problems in people with type 2 diabetes

›
Plant-based diets improve glycemic control, lead to weight loss, and improve cholesterol in people with type 2 diabetes, according to a ne...
Tuesday, December 12, 2017

Novo Nordisk Receives FDA Approval of Ozempic (semaglutide) Injection For the Treatment of Adults with Type 2 Diabetes

›
Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for Ozempic (semaglu...
Friday, September 25, 2015

Once-weekly Trulicity 0.75 mg shows promising results in Japanese patients with type 2 diabetes

›
In continuation of my update on  dapagliflozin Results from a new study of Japanese patients with type 2 diabetes showed once-we...
Wednesday, August 5, 2015

FDA Approves Glyxambi (empagliflozin and linagliptin) for Type 2 Diabetes

›
In continuation of my update on  empagliflozin The U.S. Food and Drug Administration (FDA) has approved  Glyxambi  (empagl...
Friday, October 24, 2014

Impotence Drug Might Counter Common Gene Mutation in Type 2 Diabetes

›
In a small study, Swedish researchers found that the impotence drug yohimbine might help people with type 2 diabetes who have a particular...
Monday, June 9, 2014

Isis Pharmaceuticals reports positive data from ISIS-GCGRRx Phase 2 study in patients with type 2 diabetes

›
Isis Pharmaceuticals, Inc.  announced positive data from a Phase 2 study of ISIS-GCGR Rx  in patients with type 2 diabetes uncontrolled on...
Friday, January 10, 2014

Farxiga Approved for Type 2 Diabetes - Drugs.com MedNews

›
In continuation of my update on Farxiga Farxiga (dapagliflozin) has been approved by the U.S. Food and Drug Administration to treat a...
Friday, May 3, 2013

FDA Approves Invokana to Treat Type 2 Diabetes

›
In continuation of my update on  canagliflozin/Invokana ... We know that,  Canagliflozin   ( Invokana ) is a drug for the treatment...
2 comments:
Monday, April 29, 2013

FDA Approves Invokana to Treat Type 2 Diabetes

›
In continuation of my update on Canagliflozin We know that,  Canagliflozin  ( Invokana ) is drug for the treatment of  type 2 diabete...
Friday, April 19, 2013

Takeda Receives FDA Approval for Kazano (alogliptin and metformin) for Type 2 Diabetes

›
Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved  Kazano ...
Thursday, February 7, 2013

Meta-analysis links increased magnesium intake with fasting glucose and insulin reductions...

›
"Evidence from cross-sectional and longitudinal observational studies suggests that diets higher in magnesium are associated with...
Saturday, August 18, 2012

Dapagliflozin more effective than sitagliptin for adult patients with type 2 diabetes

›
Dapagliflozin more effective than sitagliptin for adult patients with type 2 diabetes :  In continuation of my update on  dapaglifloz...
Thursday, August 16, 2012

Lexicon presents six posters on LX4211 at ADA meeting

›
  Lexicon presents six posters on LX4211 at ADA meeting : Lexicon Pharmaceuticals, Inc. will present six posters summarizing the mecha...
Tuesday, March 6, 2012

Experimental Drug Shows Promise Against Type 2 Diabetes

›
In continuation of my update on TAK 875 Experimental Drug Shows Promise Against Type 2 Diabetes : An experimental drug improves patien...
Saturday, February 25, 2012

FDA Approves Korlym for Patients with Endogenous Cushing's Syndrome..

›
Korlym (mifepristone) was approved by the U.S. Food and Drug Administration to control high blood sugar levels (hyperglycemia) in a...
Sunday, January 29, 2012

FDA Approves BYDUREON™ -- The First and Only Once-Weekly Treatment for Type 2 Diabetes

›
In continuation of my up date on Exenatide... Amylin Pharmaceuticals, Inc. and Alkermes plc today announced that the U.S. Food and Drug ...
1 comment: